RiboNova is a privately-held biopharmaceutical company based in the Lankenau Institute for Medical Research near Philadelphia, Pennsylvania. Their product pipeline includes a Phase-2 ready small molecule drug for the treatment of all forms of genetically-confirmed mitochondrial disease.

Biotechnology

Ribonova

Ribonova's headquarters in Wynnewood, PA, United States

Nigel L. Webb

Yucynthia A. Jean-Louis

Anthony W. Ford-Hutchinson

George C. Prendergast

Theodore J. Torphy

Jane H. Hollingsworth

Robert T. Sarisky

Marni J. Falk

Eric Yuen

Description